These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding. Päll T; Gad A; Kasak L; Drews M; Strömblad S; Kogerman P Oncogene; 2004 Oct; 23(47):7874-81. PubMed ID: 15361838 [TBL] [Abstract][Full Text] [Related]
3. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Zhu D; Bourguignon LY Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902 [TBL] [Abstract][Full Text] [Related]
4. A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis. Xu XM; Chen Y; Chen J; Yang S; Gao F; Underhill CB; Creswell K; Zhang L Cancer Res; 2003 Sep; 63(18):5685-90. PubMed ID: 14522884 [TBL] [Abstract][Full Text] [Related]
5. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. Liao HX; Lee DM; Levesque MC; Haynes BF J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101 [TBL] [Abstract][Full Text] [Related]
6. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. English NM; Lesley JF; Hyman R Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887 [TBL] [Abstract][Full Text] [Related]
7. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. Zhu D; Bourguignon L Oncogene; 1996 Jun; 12(11):2309-14. PubMed ID: 8649770 [TBL] [Abstract][Full Text] [Related]
9. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. Welsh CF; Zhu D; Bourguignon LY J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357 [TBL] [Abstract][Full Text] [Related]
10. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells. Subramaniam V; Gardner H; Jothy S Exp Mol Pathol; 2007 Dec; 83(3):341-6. PubMed ID: 17945213 [TBL] [Abstract][Full Text] [Related]
11. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells. Gross N; Balmas K; Brognara CB Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228 [TBL] [Abstract][Full Text] [Related]
12. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration. Zhu D; Bourguignon LY J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044 [TBL] [Abstract][Full Text] [Related]
14. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain. Liu D; Zhang D; Mori H; Sy MS Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456 [TBL] [Abstract][Full Text] [Related]
17. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid. Liu D; Liu T; Sy MS Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114 [TBL] [Abstract][Full Text] [Related]
18. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450 [TBL] [Abstract][Full Text] [Related]
19. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg. Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376 [TBL] [Abstract][Full Text] [Related]
20. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Okamoto I; Kawano Y; Tsuiki H; Sasaki J; Nakao M; Matsumoto M; Suga M; Ando M; Nakajima M; Saya H Oncogene; 1999 Feb; 18(7):1435-46. PubMed ID: 10050880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]